Introduction: Grapefruit juice (GFJ) is known to decrease the plasma concentrations of several drugs by inhibiting organic anion-transporting polypeptide (OATP) 2B1. We aimed to determine the duration of the inhibitory effect of GFJ on OATP by comparison with the duration of the GFJ-mediated effects on cytochrome P450 (CYP) 3A4 activity. Patients (or Materials) and Methods: Seven Japanese healthy subjects were enrolled and administered celiprolol (Cel) and midazolam (Mdz), which are substrates of OATP2B1 and CYP3A4, respectively, on days 1, 3, and 7 (0, 48, and 144 hours after the ingestion of GFJ). On the control day, Cel (100 mg) and Mdz (15 μ g/kg) were orally administered with water. Three days later, all subjects drank GFJ (200 mL 3 times a day) for 3 days. On day 1, the same doses of the drugs were administered with GFJ. On days 3 and 7, the subjects were administered the same doses of the drugs with water. Pharmacokinetics and hemodynamic parameters of both drugs were evaluated on each day. The plasma concentrations of Cel and Mdz were determined by LC-MS/MS. The study protocol was approved by the ethics committee of Hamamatsu University School of Medicine and University of Shizuoka, and all participants provided written informed consent before the study was initiated. Results: Plasma concentrations of Cel were lower on day 1 than on the control day. AUC0-8 and Cmax of Cel were significantly decreased on day 1, and the mean ratios of these values and the corresponding control-day values were 0.21 and 0.15, respectively. The Cmax and AUC0-8 returned to the corresponding control levels on days 3 and 7. In contrast, AUC0-8 of Mdz was higher on days 1 and 3 than on the control day, with the mean ratios of the corresponding values and control-day value being 2.00 and 1.42, respectively. The AUC0-8 returned to the control level on day 7. Systolic and diastolic blood pressure or heart rate at 1 and 3 hours after administration of drugs did not changed by the intake of GFJ. Conclusion: GFJ greatly reduced Cmax and AUC0-8 of Cel suggesting that it strongly inhibited OATP2B1. However, the OATP2B1 inhibition caused by GFJ dissipated faster than the GFJ-mediated alterations in CYP3A4 activity, which were sustained for at least 48 hours. Our results are clinically relevant because many patients take OATP substrates daily, and knowing the duration of inhibition would help patient interactions. Disclosure of Interest: None declared.
PP177-InhIbItory InteractIon of 125
Drugs wIth the renally exPresseD organIc catIon transPorter oct2: DeveloPment of a chemoInformatIcs-baseD moDel to PreDIct transPorter InhIbItIon In sIlIco K. Münch 1* ; J. Schwöbel 2 ; O. Zolk 1 ; R. Maas 1 ; L. Terfloth 2 ; and M.F. Fromm 1 1 Institute of Experimental and Clinical Pharmacology and Toxicology, and 2 Molecular Networks GmbH, Erlangen, Germany Introduction: The pivotal role of the organic cation transporter OCT2 for the renal excretion of cationic drugs raises the risk for drug-drug interactions in which 1 drug reduces OCT2-mediated elimination of a second drug. In vivo testing of drug-drug interactions is time-consuming and costly. Therefore, additional strategies are needed to predict drug-drug interactions (DDIs). We used a large set of experimental data to develop a chemoinformatics-based model to predict OCT2-inhibition in silico.
Patients (or Materials) and Methods: A total of 125 frequently prescribed drugs (inpatient prescriptions in Germany, > 4 mio. DDD each) were systematically screened for their inhibitory interaction with OCT2. As a test system, we used stably transfected HEK-OCT2 cells and 2 prototypical OCT2 substrates, [3H]1-methyl-4-phenylpyridinium ([3H]MPP+, 50µM) and [14C]metformin (1 mM). The potential inhibitors were tested at 20 and 200 µM. The experimental data were used for chemoinformatic modeling to predict OCT2-inhibition in silico. We used CORINA version 3.4 for structure processing and MOSES Descriptors Community Edition version 1.0 to calculate descriptors and pharmacophores of the test compounds. Decision tree models were developed using Weka version 3.6. Results: At 20 µM, 11% and 46%, respectively, of the tested compounds decreased OCT2-mediated uptake of [3H]MPP+ and [14C] metformin by > 50%. The most potent inhibitors of MPP+ transport via OCT2 were pantoprazole, doxepin, and clomipramine. Metformin uptake was most potently inhibited by trimipramine, trospium chloride, and doxepin. The respective IC50 values for inhibition of OCT2-mediated metformin uptake were 0.34, 0.07, and 0.50 µM. We generated a consensus decision tree model based on the experimental inhibition data. This model classified the test drugs correctly into inhibitors or noninhibitors with an overall accuracy of 76%, a positive predictive value of 83%, and a negative predictive value of 89%. Conclusion: Our decision tree model is able to predict OCT2 inhibition in silico with high reliability. If clinical data are missing, the chemoinformatics-based model might be an additional tool for the prediction of potential drug-drug interactions. Our aim is the integration of the in silico model in a medication management system. Disclosure of Interest: None declared.
